Bronte Capital Management Pty Ltd. 13F holdings, Q2 2022
Bronte Capital Management Pty Ltd. disclosed 30 US equity positions worth $828.7m in its Q2 2022 13F filing. Its largest position is GOOGL at 14.5% of the reported book, followed by BRK/B and REGN. Versus Q1 2022 it opened 2 new positions, added to 17, reduced 7 and exited 0.
- $829m
- Reported equity book Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
- 30
- Positions Distinct securities in the equity book with a reported value above zero. Options are excluded.
- 14.5%
- Largest position The largest single position as a share of the reported equity book.
- 76.5%
- Top 10 weight The ten largest positions together, as a share of the reported equity book.
- 13
- Effective positions 1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
- 31
- Quarters on file since Q4 2018 Quarters for which this manager's 13F holdings are on record.
Holdings
Against Q1 2022: 2 new, 17 added, 7 reduced, 0 exited
| GOOGL ALPHABET INC | 14.5% | +2.5% | added |
| BRK/B BERKSHIRE HATHAWAY INC DEL | 14.1% | +599% | added |
| REGN REGENERON PHARMACEUTICALS | 10.6% | +7.3% | added |
| HLF HERBALIFE LTD | 7.4% | +1.1% | added |
| V VISA INC | 7.0% | +85% | added |
| IBKR INTERACTIVE BROKERS GROUP IN | 5.9% | +13% | added |
| CTVA CORTEVA INC | 5.9% | +0.6% | added |
| IBB ISHARES TR | 4.0% | – | new |
| ATVIEUR ACTIVISION BLIZZARD INC | 3.9% | +0.5% | added |
| PINS PINTEREST INC | 3.2% | +8.6% | added |
| PM PHILIP MORRIS INTL INC | 2.4% | +33% | added |
| GHC GRAHAM HLDGS CO | 2.2% | +4.8% | added |
| HB6 HIBBETT INC | 2.0% | +144% | added |
| META META PLATFORMS INC | 2.0% | +124% | added |
| STT STATE STR CORP | 1.8% | −3.4% | reduced |
| BNY BANK OF NY MELLON CORP | 1.8% | +2697% | added |
| SQM SOCIEDAD QUIMICA Y MINERA DE | 1.7% | +4.6% | added |
| SHC SOTERA HEALTH CO | 1.6% | −12% | reduced |
| GIS GENERAL MILLS INC | 1.5% | −8.3% | reduced |
| GOOG ALPHABET INC | 1.4% | −8.0% | reduced |
| ALB ALBEMARLE CORP | 1.4% | – | new |
| MO ALTRIA GROUP INC | 1.2% | −20% | reduced |
| MDLZ MONDELEZ INTL INC | 0.6% | −23% | reduced |
| MACKEUR MERRIMACK PHARMACEUTICALS IN | 0.4% | 0.0% | held |
| BBWI BATH & BODY WORKS INC | 0.4% | −69% | reduced |
| NEM NEWMONT CORP | 0.4% | +4.7% | added |
| NPO ENPRO INC | 0.3% | +0.2% | held |
| AVLRUSD AVALARA INC | 0.2% | +119% | added |
| BNTX BIONTECH SE | 0.1% | +0.2% | held |
| DECIBEL THERAPEUTICS INC no ticker | 0.08% | +0.2% | held |
Sector mix
Book over time
Every quarter on file (31)
| Quarter | Positions | Equity book |
|---|---|---|
| Q2 2026 | 56 | $888m |
| Q1 2026 | 51 | $941m |
| Q4 2025 | 43 | $957m |
| Q3 2025 | 29 | $1.1bn |
| Q2 2025 | 27 | $1.3bn |
| Q1 2025 | 26 | $1.2bn |
| Q4 2024 | 24 | $1.3bn |
| Q3 2024 | 25 | $1.2bn |
| Q2 2024 | 28 | $1.3bn |
| Q1 2024 | 29 | $1.2bn |
| Q4 2023 | 29 | $1.1bn |
| Q3 2023 | 28 | $993m |
| Q2 2023 | 32 | $1.0bn |
| Q1 2023 | 30 | $862m |
| Q4 2022 | 27 | $793m |
| Q3 2022 | 28 | $803m |
| Q2 2022 | 30 | $829m |
| Q1 2022 | 28 | $709m |
| Q4 2021 | 24 | $770m |
| Q3 2021 | 23 | $694m |
| Q2 2021 | 17 | $666m |
| Q1 2021 | 14 | $571m |
| Q4 2020 | 13 | $517m |
| Q3 2020 | 12 | $517m |
| Q2 2020 | 10 | $446m |
| Q1 2020 | 11 | $377m |
| Q4 2019 | 7 | $344m |
| Q3 2019 | 10 | $336m |
| Q2 2019 | 9 | $263m |
| Q1 2019 | 11 | $266m |
| Q4 2018 | 9 | $239m |
Where Bronte Capital Management Pty Ltd. was early
Concentration and tenure
- 14.8%
- Median largest position, all quarters The largest single position as a share of the reported equity book.
- 79.8%
- Median top 10 weight, all quarters The ten largest positions together, as a share of the reported equity book.
- Concentrated
- Style, by median largest position
- 3
- Median completed holding, quarters